EP3638241
PHARMACEUTICAL FORMULATIONS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND SALTS THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.6.2018EP published:
25.5.2022EP application number:
18817811.5
EPO information:
European Patent Register
Max expiry date:
14.6.2038
Title in English:
PHARMACEUTICAL FORMULATIONS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND SALTS THEREOFLanguage of the patent:
English
Timeline
Today
15.6.2018EP application
25.5.2022EP Publication
Owner
Name:
Beta Pharma, Inc.Address:
1000 N. West Street Suite 1200, Wilmington, DE 19801, US
Inventor
Name:
GRECO, Michael, NicholasAddress:
Lansdale PA 19446, US
Name:
COSTANZO, Michael, JohnAddress:
Warminster PA 18974, US
Name:
GREEN, Michael, AlanAddress:
Easton PA 18040, US
Name:
PENG, JirongAddress:
Mequon WI 53097, US
Name:
WILDE, Victoria, LynnAddress:
Montclair NJ 07042, US
Name:
ZHANG, DonAddress:
Princeton NJ 08540, US
Priority
Number:
201762521007 PDate:
16.6.2017Country:
US
Classification
Categories:
A61K 31/506, A61K 31/404, C07D 239/42, C07D 401/04